Sponsored Links
| COLD-FX(R) Maker Broadens Its Scientific Direction: Launches Pilot Trial Of New Formulation LIP-01 Geared To Lowering Cholesterol And Lipids |
 |
 |
 |
| Medical News - Hematology | |||
|
Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) maker of COLD-FX announced the launch of a pilot clinical trial of a new formulation, LIP-01 that has shown promise in reducing blood lipids - including cholesterol. Cholesterol can stick to the walls of arteries, causing atherosclerosis or "hardening of the arteries... Read more: Blood / Hematology News From Medical News Today
|